Evidence map›Paper›PMID 32948771›Full record

ArticleNature communications2020

Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules.

Behnam Nabet, Fleur M Ferguson, Bo Kyung A Seong, Miljan Kuljanin, Alan L Leggett, Mikaela L Mohardt, Amanda Robichaud, Amy S Conway, Dennis L Buckley, Joseph D Mancias and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 197 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
197citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

197 citing papers in PubMed, 1 synthesis or guideline pooled it, 299 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CRISPR Gene Tagging for Illuminating Endogenous Protein Dynamics.International journal of molecular sciences · 2026
    Review
  19. Article
  20. Article

137 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Behnam Nabet *Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. behnam_nabet@dfci.harvard.edu.ORCID http://orcid.org/0000-0002-6738-4200
Fleur M Ferguson *Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-4091-7617
Bo Kyung A SeongDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Miljan KuljaninDivision of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Alan L LeggettDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mikaela L MohardtDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amanda RobichaudDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Amy S ConwayDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Dennis L BuckleyDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Joseph D ManciasDivision of Radiation and Genome Stability, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James E BradnerDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2718-4415
Kimberly StegmaierDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0003-0218-7895
Nathanael S GrayDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.ORCID http://orcid.org/0000-0001-5354-7403
Dana-Farber Cancer Institute · USHarvard University · USBroad Institute · US

Funding

The Center for Therapeutic Targeting of EWS-oncoproteinsU54CA231637 · NCI · DANA-FARBER CANCER INST · PI STEGMAIER, KIMBERLY · 2018 to 2022
$13.2M
Dissecting the Pathogenesis of Ewing Sarcoma with Integrative GenomicsR01CA204915 · NCI · DANA-FARBER CANCER INST · PI STEGMAIER, KIMBERLY, SWEET-CORDERO, ERIC ALEJANDRO · 2017 to 2021
$2.7M
NCI NIH HHS R01 CA204915NCI NIH HHS U54 CA231637
6 · The paper itself

Abstract

Chemical biology strategies for directly perturbing protein homeostasis including the degradation tag (dTAG) system provide temporal advantages over genetic approaches and improved selectivity over small molecule inhibitors. We describe dTAG

Indexed as

AnimalsFemaleGene Knockout TechniquesHEK293 CellsHumansMaleMiceMice, Inbred C57BLMice, Inbred NODMice, KnockoutModels, AnimalPeptide HydrolasesProteinsProteomicsProto-Oncogene Proteins p21(ras)Tacrolimus Binding Protein 1AHras protein, mousePeptide HydrolasesProteinsProto-Oncogene Proteins p21(ras)Tacrolimus Binding Protein 1ATacrolimus Binding ProteinsVHL protein, humanVHL protein, mouseVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID32948771
PMCPMC7501296
OpenAlexW3087526660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.